NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma.
Saved in:
| Title: | NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. |
|---|---|
| Authors: | Zhai Z; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Vaddi PK; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Samson JM; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Takegami T; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Fujita M; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, CO 80045, USA.; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2020 Dec 30; Vol. 14 (1). Date of Electronic Publication: 2020 Dec 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
